Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Myriad Genetic Laboratories, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Myriad Genetic Laboratories, Inc.

Regulatory records
1
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name Myriad Genetic Laboratories, Inc.. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Mar 10, 2026 to Mar 10, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code PJG appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P190014, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: 320 Wankara Way, Salt Lake City, UT, 84108. Recorded on P190014/S011, decision dated Mar 10, 2026.

Changes described in PMA records

P190014/S011: MyChoice CDx

FDA’s recorded scope: Approval to update the MyChoice CDx assay labeling from a complementary diagnostic to a companion diagnostic to aid in identifying ovarian cancer patients with deleterious or suspected deleterious germline or somatic BRCA1 and BRCA2 mutations and/or a positive genomic instability score, who are eligible or may become eligible for treatment with Zejula (niraparib).

Mar 10, 2026 · Normal 180 Day Track

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
MyChoice CDxP190014/S011
Myriad Genetic Laboratories, Inc.PMA supplementMar 10, 2026FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.